Riskpilot← Back to searchSign inGet full accessOCUMEDIC ApS
APSBankruptCVR 31626080Vimmelskaftet 43Wholesale of perfume and cosmetics · NACE 4645Est. 2008— employees
Revenue 2020
DKK -7K
0% vs 2019
EBITDA margin
100.0%
0% vs 2019
Equity ratio
-2.1%
Financial strength
Net profit 2020
DKK -17K
+62% vs 2019
| Revenue | DKK -7K | +0% |
| EBITDA | DKK -7K | +0% |
| Net profit | DKK -17K | +62% |
| Total assets | DKK 1,6M | +0% |
| Equity | DKK -33K | -110% |
| Employees | — | — |
Legal name
OCUMEDIC ApS
CVR number
31626080
Legal form
Anpartsselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
1. juli 2008
Share capital
DKK 160.256
Employees
—
VAT registered
No
Audit selected
No
Last report
2020-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Vimmelskaftet 43
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -52 | -13 | 0 | 0 | 0 | 0 | 0 | -6 | -6 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -52 | 466 | -15 | 0 | -6 | -6 | -6 | -6 | -6 |
| Depreciation & amort. | 204 | -172 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -256 | 293 | -15 | 0 | -6 | -6 | -6 | -6 | -6 |
| Net financials | -54 | -67 | -39 | -39 | -39 | -41 | -44 | -39 | -11 |
| Profit before tax | — | 227 | -54 | -39 | -45 | -47 | -51 | -45 | -17 |
| Tax | 77 | 53 | -0 | -171 | -10 | -0 | -0 | -0 | -0 |
| Net profit | -386 | 173 | -54 | 132 | -35 | -47 | -51 | -45 | -17 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.000 | 1.465 | 1.402 | 1.573 | 1.593 | 1.593 | 1.593 | 1.593 | 1.593 |
| Equity | — | 85 | 31 | 163 | 128 | 80 | 29 | -16 | -33 |
| Long-term debt | 541 | -561 | 567 | 567 | 567 | 567 | 567 | 567 | 567 |
| Short-term debt | 1.015 | -819 | 804 | 843 | 898 | 946 | 996 | 1.041 | 1.059 |
| Total debt | 1.555 | -1.380 | 1.371 | 1.410 | 1.465 | 1.513 | 1.563 | 1.608 | 1.626 |
EBITDA margin
-650000.0%
This company
15.8%
Market median
-4114024% vs market
20122020
Equity ratio
-2.1%
This company
38.2%
Market median
-105% vs market
20122020
Return on equity
-1722900.0%
This company
18.4%
Market median
-9363687% vs market
20122020
Net profit margin
-1722900.0%
This company
8.1%
Market median
-21270470% vs market
20122020
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20122020
Debt / equity
49.39×
This company
0.62×
Market median
-7866% vs market
20122020
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MC Unofficial title | Unofficial title | 2022 | — | — |
HB Management | Management | 2008 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2008 | |
| Individual | 25.0% | 25.0% | 2008 | |
| Individual | 20.0% | 20.0% | 2008 | |
ØYAN HOLDING ApS | Company | 20.0% | 20.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OCUMEDIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Christian Torben Serring | Unofficial title | 0 companies |
| Henning Biil | Management | 0 companies |